Actively Recruiting
Surgical or Medical Treatment of Breast Cancer Metastasis: A Multicentre Observational Study
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2023-11-14
720
Participants Needed
1
Research Sites
561 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The liver represents the third most common site of breast cancer (BC) metastases behind the lymphatics and bone. The primary treatment for BCLM remains chemo-therapy and, more recently, targeted immunotherapy. The role of liver resection in BCLM remains controversial. The primary aim of the study is to compare the efficacy of liver resection vs. medical therapy alone in Breast Cancer Liver Metastasis (BCLM) patients.
CONDITIONS
Official Title
Surgical or Medical Treatment of Breast Cancer Metastasis: A Multicentre Observational Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18 years
- Diagnosis of breast cancer liver metastases (BCLM)
- Presence of BCLM with or without disease outside the liver
- Any treatment received for BCLM
- Ability to understand and sign informed consent
You will not qualify if you...
- Unable to provide informed consent
- Patients who have received only best supportive care or palliative care
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, Lazio, Italy, 00168
Actively Recruiting
Research Team
A
Amelia Mattia, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here